Clinical trial Recruiting at 2 sites Interventional Ages 1 Day to 28 Days

Multisensory Stimulation to Ease Heel Lance Pain in Newborns

Official title: The Effect of Multisensory Stimulation Applied During Heel Blood Sampling on Pain and Physiological Parameters in Newborns: A Randomized Controlled Trial

Run by Baskent University · NCT07747649 · Data updated 2026-11-12

This randomized study tests whether a combination of breastfeeding, gentle touch, a caregiver’s voice, and eye contact can reduce pain for healthy newborns during heel blood sampling compared with standard comforting care.

Quick facts

Study typeInterventional
Ages1 Day to 28 Days
SexAll
Enrollment72 (estimated)
SponsorBaskent University
Academic / other
Locations2 sites (Ankara, Beşevler and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedAugust 15, 2026
Study endsAugust 15, 2026
Registry record updatedAugust 5, 2026
Trial IDNCT07747649 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy newborns aged 0-28 days whose parents or guardians give written informed consent and who are undergoing routine newborn care in the hospital.

Probably not a fit

Newborns with congenital conditions, lower-extremity anomalies, or those requiring NICU care may not experience benefit from this specific protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy newborns undergoing routine heel blood sampling are randomized to receive multisensory stimulation or standard caregiver comfort during the procedure. The multisensory approach includes breastfeeding, gentle leg stroking, maternal singing, and continuous eye contact starting 10 minutes before and continuing through 5 minutes after the procedure. Outcomes include pain scores, crying duration, heart rate, oxygen saturation, and total procedure time. The goal is to see if the multisensory method can lessen procedural pain and stabilize physiological responses without pharmacologic intervention.

Why it matters

Potential benefit: If successful, this approach could provide a practical, non-drug method to reduce procedural pain in newborns during routine care.

How similar studies have gone: Previous work supports non-pharmacologic strategies for neonatal pain, with mixed results; combining modalities as a multisensory approach is a logical next step but remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy newborns aged 0-28 days
* Newborns receiving routine monitoring and care with their mothers in the hospital's newborn care unit
* Written informed consent provided by the newborn's parent or legal representative

Exclusion Criteria:

* Presence of any lower-extremity anomaly
* Ongoing monitoring or treatment in the neonatal intensive care unit
* Presence of a congenital disease

Where it's running

  • Tatvan State Hospital
    Ankara, Beşevler, Turkey (Türkiye)
    Recruiting
  • Bitlis State Hospita
    Bitlis, Bitlis, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.